Grinstead Eric 4/A
4/A · SYNAGEVA BIOPHARMA CORP · Filed Jan 11, 2012
Insider Transaction Report
Form 4/AAmended
Grinstead Eric
SVP, Commercial Operations
Transactions
- Award
Stock Option (Right to Buy)
2011-12-20+40,000→ 40,000 totalExercise: $23.00Exp: 2021-12-19→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]The Option is subject to the issuer's shareholders approving an amendment to the 2005 Stock Option plan.
- [F2]This amendment is filed solely to correct a clerical error in the initial filing. In this regard the number of options acquired was incorrectly included in the disposition column rather than the acquisition column.
- [F3]25% of the total number of Shares subject to the Option vest and become exercisable on 12/20/2012 and 1/36 of the remainder of the Shares subject to the Option shall vest and become exercisable monthly thereafter.